| Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial P Moayyedi, MG Surette, PT Kim, J Libertucci, M Wolfe, C Onischi, ... Gastroenterology 149 (1), 102-109. e6, 2015 | 1559 | 2015 |
| The role of the microbiota in infectious diseases J Libertucci, VB Young Nature microbiology 4 (1), 35-45, 2019 | 323 | 2019 |
| Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis CL Hayes, J Dong, HJ Galipeau, J Jury, J McCarville, X Huang, XY Wang, ... Scientific reports 8 (1), 14184, 2018 | 161 | 2018 |
| Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis HJ Galipeau, A Caminero, W Turpin, M Bermudez-Brito, A Santiago, ... Gastroenterology 160 (5), 1532-1545, 2021 | 112 | 2021 |
| Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn’s disease J Libertucci, U Dutta, S Kaur, J Jury, L Rossi, ME Fontes, MS Shajib, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 315 (3 …, 2018 | 66 | 2018 |
| 929c A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis. P Moayyedi, M Surette, M Wolfe, R Taraschi, P Kim, J Libertucci, ... Gastroenterology 5 (146), S-159, 2014 | 34 | 2014 |
| Keeping the microbiology lab alive: essential microbiology lab skill development in the wake of COVID-19 TC Noel, JE Rubin, Y Acebo Guerrero, MC Davis, H Dietz, J Libertucci, ... Canadian journal of microbiology 66 (10), 603-604, 2020 | 30 | 2020 |
| The role of the microbiota in infectious diseases. Nat Microbiol 4: 35–45 J Libertucci, VB Young | 24 | 2019 |
| Biogeographic variation and functional pathways of the gut microbiota in celiac disease M Constante, J Libertucci, HJ Galipeau, JC Szamosi, G Rueda, ... Gastroenterology 163 (5), 1351-1363. e15, 2022 | 21 | 2022 |
| Suggestions for improving invited speaker diversity to reflect trainee diversity AK Hagan, RM Pollet, J Libertucci Journal of Microbiology & Biology Education 21 (1), 10.1128/jmbe. v21i1. 2105, 2020 | 21 | 2020 |
| The emerging roles of bacterial proteases in intestinal diseases A Caminero, M Guzman, J Libertucci, AE Lomax Gut microbes 15 (1), 2181922, 2023 | 16 | 2023 |
| Finding the silver lining during a global pandemic: opportunities for curriculum innovation in microbiology education MC Davis, J Libertucci, Y Acebo Guerrero, H Dietz, TC Noel, JE Rubin, ... Canadian Journal of Microbiology 66 (10), 600-602, 2020 | 11 | 2020 |
| Bacteria detected in both urine and open wounds in nursing home residents: a pilot study J Libertucci, CM Bassis, M Cassone, K Gibson, B Lansing, L Mody, ... Msphere 4 (4), 10.1128/msphere. 00463-19, 2019 | 11 | 2019 |
| Tu2033 Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial J Libertucci, FJ Whelan, P Moayyedi, CH Lee, M Wolfe, C Onishi, ... Gastroenterology 5 (146), S-902, 2014 | 9 | 2014 |
| The gut microbiome in patients with anxiety, depression and inflammatory bowel disease R Anglin, J Libertucci, M Wolfe, C Lee, P Moayyedi, M Surette Neuropsychopharmacology 39, S289-S289, 2014 | 3 | 2014 |
| Bacteria detected in both urine and open wounds in nursing home residents: a pilot study. mSphere 4: e00463-19 J Libertucci, CM Bassis, M Cassone, K Gibson, B Lansing, L Mody, ... | 2 | 2019 |
| Low Risk of COVID-19 Infection in an Ambulatory Gastrointestinal Endoscopy Center in Argentina C Sánchez, EF Verdu, C Cerisoli, L Caro, J Tawil, J Libertucci, ... Acta Gastroenterológica Latinoamericana 51 (2), 181-188, 2021 | 1 | 2021 |
| Policy should change to improve invited speaker diversity and reflect trainee diversity AK Hagan, RM Pollet, J Libertucci BioRxiv, 785717, 2019 | 1 | 2019 |
| Oral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trial GH Rueda, N Causada-Calo, R Borojevic, A Nardelli, MI Pinto-Sanchez, ... American Journal of Physiology-Gastrointestinal and Liver Physiology, 2024 | | 2024 |
| Crohn’s disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice A Santiago, A Hann, M Constante, S Rahmani, J Libertucci, K Jackson, ... Gut Microbes 15 (1), 2205425, 2023 | | 2023 |
